Skip to content

TELA Bio, Inc.

TELA

CIK 0001561921

← back to feed
Revenue (TTM)
$78.47M
+15.8% YoY Q1 May 2026
Net Income (TTM)
−$42.06M
−2.6% YoY Q1 May 2026
EPS Diluted (TTM)
−$0.87
+37.6% YoY Q1 May 2026
Gross Margin
67.7%
Q1 May 2026
Operating Margin
-48.0%
Q1 May 2026
Net Margin
-53.6%
Q1 May 2026
Free Cash Flow (TTM)
−$47.42M
Q1 May 2026
Cash
$39.54M
Q1 May 2026
Total Debt
$59.2M
Q1 May 2026
Shares Outstanding
44.77M sh
Q1 May 2026

Revenue & Net Income

EPS (Diluted)

Margins

Cash Flow

Revenue Growth (YoY)

Balance Sheet

Cash vs Debt

Recent filings